A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Mount Sinai researchers identify how a family of proteins activate immune cells related to inflammatory bowel disease; discovery may potentially lead to new treatments for conditions such as ulcerative colitis and Crohn's disease
Published: April 22, 2024 by Newswise - SciNews
Patent Issued for Cyclic dinucleotides as anticancer agents (USPTO 11945834)
Published: April 22, 2024 by Cancer Vaccine Daily
Healthcare professionals rank AbbVie as top player in immunology, despite competition from Pfizer and J&J, according to ZoomRx analysis; AbbVie scored highest in innovation and patient centricity, while Pfizer and J&J ranked second and third respectively
Published: April 19, 2024 by FiercePharma
AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts
Published: April 18, 2024 by PharmaBiz (India)
Sanofi's frexalimab shows high efficacy in 48-week Phase 2 trial for multiple sclerosis, with an annualized relapse rate of 0.04 for high-dose variants; Phase 3 studies have begun for both relapsing and non-relapsing secondary progressive MS
Published: April 17, 2024 by Sanofi SA

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count